CUSIP 45665G303USDINFIQQ4 2025
18 filings · latest Feb 14, 2023
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Motiv8 Investments LLC | 200 | $0 |
| 4 | Feb 14, 2022 | Polar Capital Holdings PLC | 13G | 5.6% | 5.00M | SEC |
| 5 | Feb 14, 2022 | Ecor1 Capital, LLC | 13G/A | — | — | SEC |
| 6 | Feb 14, 2022 | Biotechnology Value Fund L P | 13G/A | 3.9% | 3.43M | SEC |
| 7 | Feb 10, 2022 | Vanguard Group Inc | 13G | 6.5% | 5.78M | SEC |
| 8 | Feb 4, 2022 | Blackrock Inc. | 13G | 7.5% | 6.67M | SEC |
| 9 | Jan 18, 2022 | Integrated Core Strategies (Us) LLC | 13G/A | — | 1.5K | SEC |
| 10 | Jun 17, 2021 | Integrated Core Strategies (Us) LLC | 13G | 2.1% | 1.86M | SEC |
See the full Schedule 13D/13G history for Infinity Pharmaceuticals Inc.
Unlock full history